Tact Cool Gel
NDC Package 49873-704-01
Package Information
Tact Cool (diphenhydramine hydrochloride, levomenthol) gel is uses temporarily relieves pain and itching associated with■insect bites ■minor skin irritations ■minor cuts■scrapes ■rashes due to poison ivy ■sunburn ■minor burns. This formulation utilizes a gel delivery system. Marketed by Sato Pharmaceutical Co., Ltd., this product is identified by NDC 49873-704 and is authorized under FDA application M017.
Identification & Billing
- RxCUI: 1235317 - diphenhydrAMINE HCl 2 % / levomenthol 1 % Topical Gel
- RxCUI: 1235317 - diphenhydramine hydrochloride 0.02 MG/MG / levomenthol 0.01 MG/MG Topical Gel
- RxCUI: 1235322 - Tact Cool Jelly 2 % / 1 % Topical Gel
- RxCUI: 1235322 - diphenhydramine hydrochloride 0.02 MG/MG / levomenthol 0.01 MG/MG Topical Gel [Tact]
- RxCUI: 1235322 - Tact (diphenhydramine HCl 2 % / l-menthol 1 % ) Topical Gel
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 49873 - Sato Pharmaceutical Co., Ltd.
- 49873-704 - Tact Cool
- 49873-704-01 - 1 TUBE in 1 CARTON / 20 g in 1 TUBE
- 49873-704 - Tact Cool
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 49873-704-01 identifies a specific commercial package of 1 tube in 1 carton / 20 g in 1 tube of Tact Cool Jelly, a human over the counter drug labeled by Sato Pharmaceutical Co., Ltd.. This gel is formulated for topical use and contains diphenhydramine hydrochloride; levomenthol as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Sato Pharmaceutical Co., Ltd. on October 02, 1997. The current certification is valid through December 31, 2026.
How is this Sato Pharmaceutical Co., Ltd. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 49873070401. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.